
On CNBC’s “Halftime Report Final Trades,” Bryn Talkington of Requisite Capital Management said AbbVie Inc. (NYSE: ABBV) has a 4% yield and has underperformed this year at 10 times earnings.
AbbVie reported second-quarter adjusted EPS of $2.91, down 13.6% Y/Y, beating the consensus of $2.80.